Comprehensive analysis of recent biochemical and biologic findings regarding a newly discovered protein-PELP1/MNAR
- PMID: 16826428
- DOI: 10.1007/s10585-006-9019-9
Comprehensive analysis of recent biochemical and biologic findings regarding a newly discovered protein-PELP1/MNAR
Abstract
Estradiol (E2) and estrogen receptor (ER) signaling have been implicated in the development and progression of several cancers. Emerging evidence suggests that the status of ER coregulators in tumor cells plays an important role in hormonal responsiveness and tumor progression. Proline, glutamic acid, and leucine-rich protein-1 (PELP1/MNAR)-a novel ER coactivator that plays an essential role in the ER's actions and its expression-is deregulated in several hormonal responsive cancers. The precise function of PELP1/MNAR in cancer progression remains unclear, but PELP1 appears to function as a scaffolding protein, coupling ER with several proteins that are implicated in oncogenesis. Emerging evidence suggests that PELP1/MNAR increases E2-mediated cell proliferation and participates in E2-mediated tumorigenesis and metastasis.
Similar articles
-
Emerging significance of ER-coregulator PELP1/MNAR in cancer.Histol Histopathol. 2007 Jan;22(1):91-6. doi: 10.14670/HH-22.91. Histol Histopathol. 2007. PMID: 17128415 Free PMC article. Review.
-
Functional and biological properties of the nuclear receptor coregulator PELP1/MNAR.Nucl Recept Signal. 2007 May 17;5:e004. doi: 10.1621/nrs.05004. Nucl Recept Signal. 2007. PMID: 17525794 Free PMC article. Review.
-
Role of PELP1/MNAR signaling in ovarian tumorigenesis.Cancer Res. 2008 Jun 15;68(12):4902-9. doi: 10.1158/0008-5472.CAN-07-5698. Cancer Res. 2008. PMID: 18559538
-
PELP1/MNAR suppression inhibits proliferation and metastasis of endometrial carcinoma cells.Oncol Rep. 2012 Dec;28(6):2035-42. doi: 10.3892/or.2012.2038. Epub 2012 Sep 17. Oncol Rep. 2012. PMID: 22992812
-
PELP1: A novel therapeutic target for hormonal cancers.IUBMB Life. 2010 Mar;62(3):162-9. doi: 10.1002/iub.287. IUBMB Life. 2010. PMID: 20014005 Free PMC article. Review.
Cited by
-
Expression of estrogen receptor co-regulators NCoR and PELP1 in epithelial cells and myofibroblasts of colorectal carcinomas: cytoplasmic translocation of NCoR in epithelial cells correlates with better [corrected] prognosis.Virchows Arch. 2009 Jan;454(1):41-53. doi: 10.1007/s00428-008-0708-4. Epub 2008 Dec 2. Virchows Arch. 2009. PMID: 19048289
-
Oncogenic potential of the nuclear receptor coregulator proline-, glutamic acid-, leucine-rich protein 1/modulator of the nongenomic actions of the estrogen receptor.Cancer Res. 2007 Jun 1;67(11):5505-12. doi: 10.1158/0008-5472.CAN-06-3647. Cancer Res. 2007. PMID: 17545633 Free PMC article.
-
Role of Scaffold Protein Proline-, Glutamic Acid-, and Leucine-Rich Protein 1 (PELP1) in the Modulation of Adrenocortical Cancer Cell Growth.Cells. 2017 Nov 7;6(4):42. doi: 10.3390/cells6040042. Cells. 2017. PMID: 29112114 Free PMC article.
-
Proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor enhances androgen receptor functions through LIM-only coactivator, four-and-a-half LIM-only protein 2.Mol Endocrinol. 2007 Mar;21(3):613-24. doi: 10.1210/me.2006-0269. Epub 2006 Dec 27. Mol Endocrinol. 2007. PMID: 17192406 Free PMC article.
-
Extranuclear coactivator signaling confers insensitivity to tamoxifen.Clin Cancer Res. 2009 Jun 15;15(12):4123-30. doi: 10.1158/1078-0432.CCR-08-2347. Epub 2009 May 26. Clin Cancer Res. 2009. PMID: 19470742 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous